Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 08:05 ET | Source: NextCure

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SIM0505 for the treatment of women with platinum resistant ovarian cancer (PROC) Phase 1 data for SIM0505 to be...
April 07, 2026 08:00 ET | Source: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board

New Advisors Bring Nationwide Pharmacy and Wellness Distribution Expertise to Nugevia™ Consumer Longevity Line Compounding Pharmacy and Wellness Channels Represent Over $1.5 Billion Addressable...
April 07, 2026 08:00 ET | Source: Polyrizon Ltd.

Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement

RAANANA, ISRAEL, April 07, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today...
April 07, 2026 08:00 ET | Source: 22nd Century Group, Inc.

22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative

Company to Pursue Additional PMTA Submissions, Building on Its Status as the Only Holder of an FDA-Authorized Low Nicotine Combustible Cigarette Branded as VLN® Products Expanded PMTA Portfolio and...
April 07, 2026 08:00 ET | Source: Amneal Pharmaceuticals LLC

Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced donations totaling $2 million to multiple patient...
April 07, 2026 08:00 ET | Source: Inhibikase Therapeutics

Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension

WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary...
April 07, 2026 08:00 ET | Source: Smithfield Foods, Inc.

Smithfield® and Pabst Blue Ribbon Kick Off Grilling Season with a Bold New Beer Brat

Smithfield® and Pabst Blue Ribbon Kick Off Grilling Season with a Bold New Beer Brat
April 07, 2026 08:00 ET | Source: ASML Netherlands BV

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share...
April 07, 2026 08:00 ET | Source: Evaxion

Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01

Trial extension completed as planned with three-year clinical efficacy data expected to be presented in the second half of 2026The trial has already yielded encouraging one- and two-year data...
April 07, 2026 08:00 ET | Source: Rubico Inc.

Rubico Inc. Announces Reverse Stock Split

ATHENS, Greece, April 07, 2026 (GLOBE NEWSWIRE) -- Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of...